Viewing Study NCT03128359


Ignite Creation Date: 2025-12-24 @ 2:47 PM
Ignite Modification Date: 2026-01-17 @ 2:25 PM
Study NCT ID: NCT03128359
Status: COMPLETED
Last Update Posted: 2024-01-09
First Post: 2017-03-24
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant
Sponsor: City of Hope Medical Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 16419
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View